| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1002504871 |
| P356 | DOI | 10.1038/SREP26252 |
| P932 | PMC publication ID | 4870583 |
| P698 | PubMed publication ID | 27188220 |
| P2093 | author name string | Hua Zhang | |
| Nan Li | |||
| Xiang Hu | |||
| Xuetao Cao | |||
| Jing Jin | |||
| Chaofeng Han | |||
| Tianliang Li | |||
| Kewei Qin | |||
| P2860 | cites work | Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation | Q24312168 |
| Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice | Q24523182 | ||
| Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b | Q28506491 | ||
| Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation | Q28512759 | ||
| Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins | Q28588506 | ||
| Mycobacteria target DC-SIGN to suppress dendritic cell function | Q28616857 | ||
| Interleukin-10-deficient mice develop chronic enterocolitis | Q29547881 | ||
| The regulation of IL-10 production by immune cells | Q29615479 | ||
| Recognition of microorganisms and activation of the immune response | Q29617903 | ||
| Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10 | Q83181554 | ||
| Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis | Q30434426 | ||
| E3 ubiquitin ligase Cbl-b in innate and adaptive immunity | Q33953086 | ||
| Identification of a role for the PI3K/AKT/mTOR signaling pathway in innate immune cells | Q35144129 | ||
| Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function | Q35884586 | ||
| CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation | Q36229469 | ||
| Treatment of dextran sodium sulfate-induced experimental colitis by adoptive transfer of peritoneal cells. | Q36275547 | ||
| Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. | Q36941065 | ||
| Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression | Q36983876 | ||
| Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor-induced interleukin 12 synthesis. | Q37098840 | ||
| The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls | Q37139051 | ||
| The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications | Q37331097 | ||
| Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis. | Q37408857 | ||
| The ins and outs of leukocyte integrin signaling | Q37419383 | ||
| Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review | Q38091913 | ||
| Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response | Q38118313 | ||
| Why interleukin-10 supplementation does not work in Crohn's disease patients. | Q38120519 | ||
| IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms | Q38227341 | ||
| Interleukin-10 receptor mutations in children with neonatal-onset Crohn's disease and intractable ulcerating enterocolitis. | Q38448841 | ||
| Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease | Q38681728 | ||
| A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation | Q38855496 | ||
| Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. | Q39669362 | ||
| Chemically induced mouse models of intestinal inflammation | Q42510602 | ||
| Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations. | Q44591687 | ||
| Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO. | Q45718626 | ||
| The history of Toll-like receptors - redefining innate immunity. | Q46240771 | ||
| Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflammation | Q46339677 | ||
| A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells | Q47810460 | ||
| Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. | Q52956682 | ||
| ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. | Q53003283 | ||
| Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome. | Q53201131 | ||
| Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. | Q53587595 | ||
| IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. | Q54600671 | ||
| Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. | Q54709609 | ||
| Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis | Q57339877 | ||
| Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation | Q58807981 | ||
| Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases | Q60175418 | ||
| MyD88-dependent autoimmune disease in Lyn-deficient mice | Q60444744 | ||
| Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells | Q61645726 | ||
| Tumour necrosis factor alpha in stool as a marker of intestinal inflammation | Q67512879 | ||
| P2507 | corrigendum / erratum | Author Correction: Integrin CD11b attenuates colitis by strengthening Src-Akt pathway to polarize anti-inflammatory IL-10 expression | Q101564272 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 26252 | |
| P577 | publication date | 2016-05-18 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Integrin CD11b attenuates colitis by strengthening Src-Akt pathway to polarize anti-inflammatory IL-10 expression | |
| P478 | volume | 6 |
| Q89689733 | Integrin CD11b Deficiency Aggravates Retinal Microglial Activation and RGCs Degeneration After Acute Optic Nerve Injury |
| Q54108748 | Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization. |
| Q57039639 | [EXPRESS] CD11b activated Src signal attenuates neuroinflammatory pain by orchestrating inflammatory and anti-inflammatory cytokines in microglia |
Search more.